# Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy

> **NCT03239535** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Federal Research Clinical Center of Federal Medical & Biological Agency, Russia** · enrollment: 40 (estimated)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells
- **BIOLOGICAL:** Normal saline

## Key facts

- **NCT ID:** NCT03239535
- **Lead sponsor:** Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239535, "Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03239535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*